Dhruvajyoti (Dhruv) Roy, Ph.D., Director of Technology at Helio Genomics, has joined the Editorial Advisory Board of Onco’Zine, an online oncology and hematology journal.
Onco’Zine, an online journal and digital platform covering all aspects of oncology and hematology, published by Sunvalley Communication, LLC, has announced that Dhruvajyoti (Dhruv) Roy, Ph.D., Director of Technology at Helio Genomics, Inc., has joined the publication’s Editorial Advisory Board.
As a member of the editorial advisory board, Dr. Roy will help guide the publication’s editorial staff to ensure its science-driven content stays atop critical topics, issues, and concerns that affect the oncology (academic, research & development and clinical) community and the larger biotechnology industry sector.
“Dr. Roy’s experience will be invaluable as we accelerate our global editorial mission and grow the journal. We are excited to have Dhruv on our Editorial Advisory Board and look forward to working closely with him. We admire Dr. Roy’s expertise in liquid biopsies as well as his keen and intimate understanding of the early diagnosis of cancer.”
“I am privileged to be a member of the advisory board for Onco’Zine and to be associated with such an esteemed team of academic and industry experts. I am excited to collaborate with this team of clinicians, translational researchers, clinical trial experts and oncology pioneers to guide the editorial decisions and strategy for the journal.”
Dr. Roy is the Director of Technology at Helio Genomics, Inc., an AI-driven healthcare company focused on commercializing early cancer detection tests from a simple blood draw. He received his Ph.D. in Chemistry and Nano-biotechnology from the Pohang University of Science and Technology (POSTECH) in South Korea, and has more than 12 years of substantive research experience in biotechnology, combining extensive technical, bio-analytical and interpretive skills with practical laboratory experience in Next-generation Sequencing (NGS) and liquid biopsies including CTCs, exosomes, and circulating cell-free nucleic acid-based tests.
Dr. Roy is a member of the American Society of Clinical Oncology (ASCO), a senior member of IEEE, and a Sigma Xi member of the Scientific Research Honor Society. He is also associated with several prestigious peer-reviewed journals as a reviewer, editor and editorial board member, including Langmuir, Lab on a Chip, Analytical and Bioanalytical Chemistry, Molecular Cancer Therapeutics, Clinical Cancer Research, and Translational Oncology, among others.
About Onco’Zine
Onco’Zine is an online journal and digital platform covering all aspects of oncology and hematology, published by Sunvalley Communication, LLC. Its primary focus is to inform, educate, and support physicians and healthcare professionals treating cancer patients, reporting on current research and development in oncology and hematology.
Source: Sunvalley Communication, LLC. Read the full announcement.